Reportee | Signature Date | Report period | Total Entries | Total AUM($) |
---|---|---|---|---|
HUDSON BAY CAPITAL MANAGEMENT LP | 02-14-2024 | 12-31-2023 | 712 | 15,773,357,985 |
Issuer | Class | Position | Value | Shares | Portfolio Percentage (%) | Previous Percentage (%) | Shares Delta | Shares Delta(%) | Date Reported |
---|---|---|---|---|---|---|---|---|---|
APELLIS PHARMACEUTICALS INC | COM | Liquidated | $0 | 0 | 0.00 | 12,500 | +Inf | 12-31-2023 | |
MACROGENICS INC | COM | 2352 | $473,237 | 49,193 | 0.00 | 49,193 | +Inf | 12-31-2023 | |
AURA BIOSCIENCES INC | COM | 2353 | $470,218 | 53,072 | 0.00 | 53,072 | +Inf | 12-31-2023 | |
CRISPR THERAPEUTICS AG | NAMEN AKT | Liquidated | $0 | 0 | 0.00 | 0.00 | -20,000 | -66.67 | 12-31-2023 |